TransMedics (TMDX) Total Non-Current Liabilities (2022 - 2026)
TransMedics' (TMDX) quarterly Total Non-Current Liabilities came in at $936.8 million in Q1 2026, up 66.47% quarter-over-quarter from $562.8 million in Q3 2023.
TransMedics (TMDX) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends
TransMedics' Total Non-Current Liabilities history runs 3 years deep, the most recent figure standing at $936.8 million for Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities changed N/A year-over-year to $936.8 million in Q1 2026; TTM through Mar 2026 was $936.8 million, a N/A change from a year earlier, with the FY2022 full-year figure at $89.8 million, changed N/A from the prior year.
- Total Non-Current Liabilities improved to $936.8 million in Q1 2026 per TMDX's latest filing, from $562.8 million in the prior quarter.
- Across five years, Total Non-Current Liabilities topped out at $936.8 million in Q1 2026 and bottomed at $89.8 million in Q4 2022.
- The 3-year median for Total Non-Current Liabilities is $545.1 million (2023), against an average of $445.8 million.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 41.44 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 41.88 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.64 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 3.53 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 9.85 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 3.57 Bn |
| 10 | TransMedics | 2.45 Bn | 1.98 Bn | 101.16 Mn | 936.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 936.83 Mn |
| Sep 30, 2023 | 562.77 Mn |
| Jun 30, 2023 | 545.15 Mn |
| Mar 31, 2023 | 94.46 Mn |
| Dec 31, 2022 | 89.77 Mn |